Harpeth Capital is a boutique investment banking firm that specializes in mergers and acquisitions advisory, capital raising and financial advisory services for middle market clients. self-described.

Harpeth Capital, LLC

Harpeth Capital

Harpeth Capital, LLC | 622 followers on LinkedIn. Middle market investment bank and venture capital firm. | Founded in 1999, Harpeth Capital, LLC is a boutique investment banking firm specializing in merger and acquisition, strategic advisory and capital raising services to private and public companies in the middle market.   In addition, Harpeth Fund Advisors offers fund placement services to PE groups.  Through Harpeth Ventures, we invest growth capital in young companies.

CEO - Harpeth Capital, LLC

Chuck Byrge

Director Division of Cardiothoracic Surgery at TriStar Centennial Medical Center

V Seenu Reddy MD MBA FACS FACC

Professor Van Horn leads Preverity in the establishment of a national patient safety platform for US healthcare

Larry Van Horn

Associate at Harpeth Capital, LLC

Zachary Varner, CFA

HARPETH CAPITAL CELEBRATES 25 YEAR ANNIVERSARY This year marks Harpeth Capital’s 25th anniversary. I want to thank everyone that joined us at City Winery recently to celebrate. It was special to visit with so many friends, clients and colleagues that we have had the pleasure of interacting with over the last 25 years. We are honored to have been trusted by so many great companies, founders, families and executives over the years and value all the teammates that have contributed to our success and longevity since 1999. We look forward to many years to come.

HARPETH CAPITAL SERVES AS FINANCIAL ADVISOR TO RHYTHMEDIX Harpeth Capital is pleased to announce that it served as exclusive financial advisor to RhythMedix, LLC in connection with a majority investment from Pharos Capital Group. The senior leadership of RhythMedix has maintained a significant equity stake in the company. Harpeth Ventures also invested along side Pharos and management. RhythMedix is a leading integrated platform transforming ambulatory cardiac monitoring by providing cutting-edge cardiac hardware and continuous, cloud-based remote monitoring solutions serving physicians and their patients nationwide. Heart disease is the leading cause of death in the United States, with arrhythmia and other detectable conditions more than doubling the risk of death. Supported by proprietary technology leveraging machine learning, AI, and other related algorithm data analysis, the company's team of experienced, certified technicians verify every heartbeat in near real-time, reducing missed events while providing transparency to full-disclosure data. "We are extremely grateful to Harpeth Capital for their support and guidance throughout the process," said Brian Pike, President and Co-Founder of RhythMedix. “They introduced us to many great groups and helped the company shine every step of the way - from drafting the CIM to introductory calls to management visits to post-LOI diligence. With the experience and resources of the Pharos team, we could not be more excited about the opportunities to further build upon what we believe to be the best solution available to physicians, practices, health systems, and, most importantly, their patients." Adam Landa, Managing Director of Harpeth Capital, shared his thoughts on the transaction, "We love working with founders like Brian and Stan, who saw a need and launched RhythMedix with a goal to improve patient outcomes and make ambulatory cardiac monitoring almost effortless."

HARP

COM:HARPETHCAPITAL

Harpeth Capital

name

homepage url

country

linkedin url

crunchbase url

sector

industry

monthly webtraffic

monthly webtraffic growth

Description

peer of

Metrics